133 related articles for article (PubMed ID: 32453447)
21. Prognostic features of endometrial cancer metastasis to the central nervous system.
Kuznicki ML; Mallen A; Ha K; McClung EC; Castaneda AV; Cao B; Fridley BL; Chon HS; Chern JY; Hoffman M; Wenham RM; Matsuo K; Shahzad MMK
PLoS One; 2022; 17(8):e0268794. PubMed ID: 36018828
[TBL] [Abstract][Full Text] [Related]
22. Ventriculoperitoneal Shunt for CNS Metastasis in Breast Cancer: Clinical Outcomes Based on Intrinsic Subtype.
Kim HK; Lee HS; Heo MH; Kim JY; Ahn JS; Im YH; Lee JI; Park YH
Clin Breast Cancer; 2021 Aug; 21(4):e402-e414. PubMed ID: 33526378
[TBL] [Abstract][Full Text] [Related]
23. Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.
Morikawa A; Wang R; Patil S; Diab A; Yang J; Hudis CA; McArthur HL; Beal K; Seidman AD
Clin Breast Cancer; 2018 Oct; 18(5):353-361. PubMed ID: 29337140
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis.
Altundag K; Bondy ML; Mirza NQ; Kau SW; Broglio K; Hortobagyi GN; Rivera E
Cancer; 2007 Dec; 110(12):2640-7. PubMed ID: 17960791
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer subtypes and outcomes of central nervous system metastases.
Arslan UY; Oksuzoglu B; Aksoy S; Harputluoglu H; Turker I; Ozisik Y; Dizdar O; Altundag K; Alkis N; Zengin N
Breast; 2011 Dec; 20(6):562-7. PubMed ID: 21871802
[TBL] [Abstract][Full Text] [Related]
27. Risk and prognostic factors of breast cancer with liver metastases.
Ji L; Cheng L; Zhu X; Gao Y; Fan L; Wang Z
BMC Cancer; 2021 Mar; 21(1):238. PubMed ID: 33676449
[TBL] [Abstract][Full Text] [Related]
28. Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype.
Arvold ND; Oh KS; Niemierko A; Taghian AG; Lin NU; Abi-Raad RF; Sreedhara M; Harris JR; Alexander BM
Breast Cancer Res Treat; 2012 Nov; 136(1):153-60. PubMed ID: 22968656
[TBL] [Abstract][Full Text] [Related]
29. Central nervous system metastases in breast cancer: the impact of age on patterns of development and outcome.
Ben-Zion Berliner M; Yerushalmi R; Lavie I; Benouaich-Amiel A; Tsoref D; Hendler D; Goldvaser H; Sarfaty M; Rotem O; Ulitsky O; Siegal T; Neiman V; Yust-Katz S
Breast Cancer Res Treat; 2021 Jan; 185(2):423-432. PubMed ID: 33037977
[TBL] [Abstract][Full Text] [Related]
30. Clinical features and survival analysis of different subtypes of patients with breast cancer brain metastases.
Bai B; Yuan ZY; Liu DG; Teng XY; Wang SS
Chin J Cancer; 2010 Apr; 29(4):413-9. PubMed ID: 20346218
[TBL] [Abstract][Full Text] [Related]
31. Development of CNS metastases and survival in patients with inflammatory breast cancer.
Uemura MI; French JT; Hess KR; Liu D; Raghav K; Hortobagyi GN; Arun BK; Valero V; Ueno NT; Alvarez RH; Woodward WA; Debeb BG; Moulder SL; Lim B; Tripathy D; Ibrahim NK
Cancer; 2018 Jun; 124(11):2299-2305. PubMed ID: 29579338
[TBL] [Abstract][Full Text] [Related]
32. Use and Yield of Baseline Imaging and Laboratory Testing in Stage II Breast Cancer.
Bychkovsky BL; Guo H; Sutton J; Spring L; Faig J; Dagogo-Jack I; Battelli C; Houlihan MJ; Yeh TC; Come SE; Lin NU
Oncologist; 2016 Dec; 21(12):1495-1501. PubMed ID: 27551013
[TBL] [Abstract][Full Text] [Related]
33. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
Liu ZF; Chen C; Yao XL; Sun SR
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
[TBL] [Abstract][Full Text] [Related]
34. Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers.
Song Y; Barry WT; Seah DS; Tung NM; Garber JE; Lin NU
Cancer; 2020 Jan; 126(2):271-280. PubMed ID: 31581314
[TBL] [Abstract][Full Text] [Related]
35. Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER.
Brufsky AM; Mayer M; Rugo HS; Kaufman PA; Tan-Chiu E; Tripathy D; Tudor IC; Wang LI; Brammer MG; Shing M; Yood MU; Yardley DA
Clin Cancer Res; 2011 Jul; 17(14):4834-43. PubMed ID: 21768129
[TBL] [Abstract][Full Text] [Related]
36. Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database.
Kim YJ; Kim JS; Kim IA
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1803-1816. PubMed ID: 29971531
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of breast cancer patients with central nervous system metastases: a single-center experience.
Harputluoglu H; Dizdar O; Aksoy S; Kilickap S; Dede DS; Ozisik Y; Guler N; Barista I; Gullu I; Hayran M; Selek U; Cengiz M; Zorlu F; Tekuzman G; Altundag K
J Natl Med Assoc; 2008 May; 100(5):521-6. PubMed ID: 18507204
[TBL] [Abstract][Full Text] [Related]
38. Treatment and prognosis of breast cancer patients with brain metastases according to intrinsic subtype.
Kuba S; Ishida M; Nakamura Y; Yamanouchi K; Minami S; Taguchi K; Eguchi S; Ohno S
Jpn J Clin Oncol; 2014 Nov; 44(11):1025-31. PubMed ID: 25156682
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.
Diessner J; Wischnewsky M; Stüber T; Stein R; Krockenberger M; Häusler S; Janni W; Kreienberg R; Blettner M; Schwentner L; Wöckel A; Bartmann C
BMC Cancer; 2016 May; 16():307. PubMed ID: 27175930
[TBL] [Abstract][Full Text] [Related]
40. The shifting landscape of metastatic breast cancer to the CNS.
Quigley MR; Fukui O; Chew B; Bhatia S; Karlovits S
Neurosurg Rev; 2013 Jul; 36(3):377-82. PubMed ID: 23262837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
